General Biologicals Corporation (TPEX:4117)
Taiwan · Delayed Price · Currency is TWD 9.16
-0.09 (-0.97%)
Sep 8, 2026, 1:45 PM CST
General Biologicals Market Cap
General Biologicals has a market cap or net worth of 654.83 million as of September 8, 2026. Its market cap has decreased by -33.34% in one year.
Market Cap
654.83M
Enterprise Value
2.58B
Revenue
260.23M
Ranking
n/a
PE Ratio
1.21
Stock Price
9.16
ChartMarket Cap Chart
Since February 21, 2005, General Biologicals's market cap has increased from 326.98M to 654.83M, an increase of 100.27%. That is a compound annual growth rate of 3.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 654.83M | -16.22% |
| Dec 31, 2025 | 781.59M | -38.66% |
| Dec 31, 2024 | 1.27B | -21.11% |
| Dec 29, 2023 | 1.62B | 0.37% |
| Dec 30, 2022 | 1.61B | -22.70% |
| Dec 30, 2021 | 2.08B | -35.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InnoPharmax | 1.34B |
| GeneFerm Biotechnology | 1.25B |
| Excelsior Biopharma | 1.14B |
| Prince Pharmaceutical | 1.06B |
| DV Biomed | 999.53M |
| Anxo Pharmaceutical | 972.28M |
| Original BioMedicals | 935.31M |
| Winston Medical Supply | 827.84M |